Cite
APA Citation
Chang, L., Meng, Y., Janosczyk, H., Landolfi, V., Talbot, H. K., & , (2019). safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults ≥65 years of age: A phase 3 randomized clinical trial. Vaccine, 37(39), 5825–5834. http://access.bl.uk/ark:/81055/vdc_100090080908.0x000034